295 related articles for article (PubMed ID: 31785006)
1. Serum IgA Fc effector functions in infectious disease and cancer.
Davis SK; Selva KJ; Kent SJ; Chung AW
Immunol Cell Biol; 2020 Apr; 98(4):276-286. PubMed ID: 31785006
[TBL] [Abstract][Full Text] [Related]
2. The Fc receptor for IgA (FcalphaRI, CD89).
Otten MA; van Egmond M
Immunol Lett; 2004 Mar; 92(1-2):23-31. PubMed ID: 15081523
[TBL] [Abstract][Full Text] [Related]
3. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
Breedveld A; van Egmond M
Front Immunol; 2019; 10():553. PubMed ID: 30984170
[TBL] [Abstract][Full Text] [Related]
4. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
Front Immunol; 2019; 10():704. PubMed ID: 31031746
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin A: magic bullet or Trojan horse?
Heineke MH; van Egmond M
Eur J Clin Invest; 2017 Feb; 47(2):184-192. PubMed ID: 28024097
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
Ben Mkaddem S; Rossato E; Heming N; Monteiro RC
Autoimmun Rev; 2013 Apr; 12(6):666-9. PubMed ID: 23201915
[TBL] [Abstract][Full Text] [Related]
7. IgA and the IgA Fc receptor.
van Egmond M; Damen CA; van Spriel AB; Vidarsson G; van Garderen E; van de Winkel JG
Trends Immunol; 2001 Apr; 22(4):205-11. PubMed ID: 11274926
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
9. The human IgA-Fc alpha receptor interaction and its blockade by streptococcal IgA-binding proteins.
Woof JM
Biochem Soc Trans; 2002 Aug; 30(4):491-4. PubMed ID: 12196121
[TBL] [Abstract][Full Text] [Related]
10. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
Aleyd E; Heineke MH; van Egmond M
Immunol Rev; 2015 Nov; 268(1):123-38. PubMed ID: 26497517
[TBL] [Abstract][Full Text] [Related]
11. Structure and function of human IgA Fc receptors (Fc alpha R).
Morton HC; van Egmond M; van de Winkel JG
Crit Rev Immunol; 1996; 16(4):423-40. PubMed ID: 8954257
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcalphaRI (CD89).
van der Pol W; Vidarsson G; Vilé HA; van de Winkel JG; Rodriguez ME
J Infect Dis; 2000 Oct; 182(4):1139-45. PubMed ID: 10979910
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of equine CD89 and identification of the CD89 gene in chimpanzees and rhesus macaques.
Morton HC; Pleass RJ; Storset AK; Brandtzaeg P; Woof JM
Immunology; 2005 May; 115(1):74-84. PubMed ID: 15819699
[TBL] [Abstract][Full Text] [Related]
14. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
Front Immunol; 2018; 9():244. PubMed ID: 29651286
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulins and their receptors, and subversion of their protective roles by bacterial pathogens.
Woof JM
Biochem Soc Trans; 2016 Dec; 44(6):1651-1658. PubMed ID: 27913674
[TBL] [Abstract][Full Text] [Related]
16. Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA.
Cottignies-Calamarte A; Tudor D; Bomsel M
Front Immunol; 2023; 14():1037033. PubMed ID: 36817447
[TBL] [Abstract][Full Text] [Related]
17. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
Herr AB; Ballister ER; Bjorkman PJ
Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
[TBL] [Abstract][Full Text] [Related]
18. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
Huls G; Heijnen IA; Cuomo E; van der Linden J; Boel E; van de Winkel JG; Logtenberg T
Cancer Res; 1999 Nov; 59(22):5778-84. PubMed ID: 10582699
[TBL] [Abstract][Full Text] [Related]
19. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
van Erp EA; Luytjes W; Ferwerda G; van Kasteren PB
Front Immunol; 2019; 10():548. PubMed ID: 30967872
[TBL] [Abstract][Full Text] [Related]
20. Nonhuman primate IgA: genetic heterogeneity and interactions with CD89.
Rogers KA; Jayashankar L; Scinicariello F; Attanasio R
J Immunol; 2008 Apr; 180(7):4816-24. PubMed ID: 18354205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]